RNU6-732P

Across TCGA pan-cancer cohorts, RNU6-732P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU6-732P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RNU6-732P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-732P expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

OV, UCEC, and KIRC are the cancer types where RNU6-732P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	II,III,IV	0.083	0.844	<.001	144	view →
UCEC	OS	Tertile	All	0.195	0.875	<.001	108	view →
KIRC	OS	Tertile	All	0.397	0.883	.002	78	view →
SKCM	DFS	Tertile	II,III,IV	0.824	0.211	.012	45	view →
BRCA	DFS	Tertile	All	0.664	0.903	<.001	42	view →
LUAD	DFS	Tertile	IV	0.045	0.717	<.001	36	view →
LAML	DFS	Tertile	All	0.192	0.489	.049	18	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU6-732P–OV (OS)

Open the OV breakdown →